Mayne Pharma launches BAC 300 capsules in the United States |
| May 22, 2020 | May 2020 Bond Updates |
|
ADELAIDE, Australia, May 22, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the launch of butalbital acetaminophen and caffeine (BAC) capsule 50mg/300mg/40mg in the United States. Mayne Pharma received approval from the US Food and Drug Administration... |
| View more at: https://www.prnewswire.com:443/news-releases/mayne-pharma-launches-bac-300-capsules-in-the-united-states-301064172.html |
| Related News |
|